Position in GSK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$48,074,748
-$713,046 QoQ
Shares Held
917,107
+3.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#47
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$391,680
PutShares
10,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $5,886,151,720 across 17 Drug Manufacturers - General names. GSK ranks #13 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,274,807 | $1,529,041,887 | |
| 2 | JNJ |
Johnson & Johnson
|
5,055,143 | $1,283,854,667 | |
| 3 | ABBV |
AbbVie Inc.
|
4,096,323 | $1,030,798,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,836,733 | $493,020,190 | |
| 5 | AMGN |
Amgen Inc
|
1,188,164 | $430,257,947 | |
| 6 | PFE |
Pfizer Inc
|
13,919,821 | $335,189,289 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,265,381 | $188,151,253 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
969,813 | $122,526,174 |
All Filings in GSK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,074,748 | 917,107 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $48,787,794 | 883,997 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $77,588,292 | 1,582,143 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $72,138,832 | 1,671,428 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $63,154,444 | 1,644,647 | Shares | Sole | 2025-08-12 | |
| 2025-06-30 | $391,680 | 10,200 | Put | Sole | 2025-08-12 | |
| 2025-03-31 | $26,103,554 | 673,814 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $20,389,570 | 602,885 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $23,888,882 | 584,366 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $21,280,567 | 552,742 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $23,478,698 | 547,672 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $20,632,413 | 556,730 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,008,506 | 579,545 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $18,559,708 | 520,755 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $15,929,521 | 447,710 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $12,744,504 | 362,678 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $12,464,958 | 423,546 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,590,938 | 505,711 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $18,698,303 | 437,657 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,748,090 | 433,449 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,561,555 | 388,553 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $15,238,540 | 390,177 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $13,177,188 | 376,440 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,383,582 | 315,392 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $20,700,349 | 560,722 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $25,737,035 | 643,316 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $24,458,209 | 658,142 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||